Okami Medical is a privately held medical technology company focused on creating versatile, intuitive devices for peripheral vascular occlusion. Founded in 2017 by Inceptus Medical and headquartered in Aliso Viejo, California, the company’s flagship product is the LOBO vascular occluder, which has demonstrated clinical performance across a wide range of anatomies. Okami’s mission is to stop blood flow where needed and thereby restore patients’ lives, addressing significant unmet needs in vascular disease treatment. With its latest capital infusion, the company plans to accelerate commercial expansion, advance ongoing clinical programs, and fuel continued product innovation. The leadership team was recently strengthened by the appointment of former Inari Medical CEO Drew Hykes as President and CEO, and Bill Hoffman as Chairman of the Board. Okami positions itself at the intersection of med-tech innovation and improved patient care, leveraging a growing base of investor support to scale its technology.

Total raised

$57M

Funding rounds

3

Latest round

Equity

Latest activity

Nov 2025